Advisors Asset Management Inc. Has $8.35 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisors Asset Management Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,997 shares of the medical equipment provider’s stock after buying an additional 1,757 shares during the quarter. Advisors Asset Management Inc.’s holdings in Intuitive Surgical were worth $8,350,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $82,517,000. Sycomore Asset Management increased its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. increased its stake in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $483.95 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a 50-day moving average price of $565.43 and a two-hundred day moving average price of $531.90. The firm has a market cap of $172.37 billion, a price-to-earnings ratio of 75.50, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Activity

In related news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on ISRG shares. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Truist Financial reduced their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday. Finally, BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.